Since 1955, when Dr Alan Stead reported that newborn infants appeared resistant to suxamethonium and sensitive to d-tubocurarine, I many others have investigated the effects of neuromuscular blocking drugs in children. In this issue, we publish a body of such work, emanating from the cooperation of paediatric anaesthetists from Helsinki and Melbourne. The authors deserve congratulations on their enormous effort and persistance in collecting and collating such extensive data.
The first papers in this mini-symposium clarify dose-response relationships in the various paediatric age groups. The results for alcuronium are of special interest, as no information on the requirements for this drug in children has been published previously. Other papers in the group discuss the alterations in normal doseresponsiveness which occur in children with tumours, in myasthenia and after treatment with other drugs. Common to all these articles, however, is one essential element -the measurement of neuromuscular blockade. Two other papers discuss this form of monitoring; while one is not part of the mini-symposium, it provides a valuable complement to it.
The Faculty of Anaesthetists of the Royal Australasian College of Surgeons, in its policy on monitoring, states: 'Equipment to monitor neuromuscular function must be available for those patients in whom neuromuscular paralysis has been induced.'2 In fact, few anaesthetists use such equipment, feeling secure in the 'knowledge' that the doses of relaxants they use have predictable durations of action. Even the advent of the Anaesthesia and Intensive Care, Vol. 18, No. 4, November, 1990 intermediate duration nondepolarising drugs has failed to change their indifference to this form of monitoring, despite the often sudden clinical recovery seen with atracurium and vecuronium. Undoubtedly, this lack of interest stems partly from both the inconvenience sometimes associated with peripheral nerve stimulators and the fact that the diaphragm and muscles of the larynx are more resistant to the effects of the nondepolarising drugs than are the peripheral muscles. However, as pointed out by Professor John Norman, only continuous monitoring can predict with any accuracy when further doses of relaxants are needed and when antagonism can be expected to produce fast or slow reversal of paralysis. 3 The papers presented here affirm this opinion of the value of properly conducted neuromuscular monitoring, in normal as well as unusual situations. One would hope that this symposium will not only be of value for the information that it offers those who deal with children, but will enkindle more enthusiasm for the measurement of blockade by all anaesthetists.
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